At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney, Australia, discusses current research into treatments that target mechanistic events in the development of melanoma, and how the results of such research can be applied in clinical practice.
Developing targeted therapies for melanoma
21st August 2015
Oncology
Please rate the quality of this content
We are sorry that this content was not interesting for you!
Let us improve this content!
Tell us how we can improve this content?